Rankings
▼
Calendar
ARCT FY 2019 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$210M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21M
+32.0% YoY
Gross Profit
$21M
100.0% margin
Operating Income
-$26M
-122.7% margin
Net Income
-$26M
-125.0% margin
EPS (Diluted)
$-2.13
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$82M
Total Liabilities
$56M
Stockholders' Equity
$26M
Cash & Equivalents
$71M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$16M
+32.0%
Gross Profit
$21M
-$1M
+1791.5%
Operating Income
-$26M
-$22M
-17.0%
Net Income
-$26M
-$22M
-19.3%
← Q4 2018
All Quarters
Q1 2019 →